Results 191 to 200 of about 45,756 (238)

Development of a F22 Compatible Scale Inhibitor

CONFERENCE 2022, 2022
Abstract F22, a low alloy steel, has become widely used in oil field production systems. However, current scale inhibitor technologies on the market often cause severe corrosion on F22, particularly at high temperature conditions. Therefore, F22 compatible scale inhibitors are in demand in the oil and gas industry. A F22 compatible scale
Ya Liu   +4 more
openaire   +2 more sources

Development of an F22 Metal Compatible Scale Inhibitor for Subsea Application

CONFERENCE 2023, 2023
Abstract F22 carbon steel has been widely used in subsea field development due to enhanced mechanical properties. However, commonly used scale inhibitors have been shown to be very corrosive against F22, and therefore cannot be injected continuously subsea to control mineral scales. In this paper, inhibition performances of several scale
Chunfang Fan   +5 more
openaire   +2 more sources

F22. Duration of burst suppression in status epilepticus: A retrospective analysis

Clinical Neurophysiology, 2018
Introduction Pharmacologically induced burst suppression (BS) is used in the management of status epilepticus (SE), however prolonged duration of BS is associated with adverse outcomes. The optimal period of burst suppression is not known. We investigated the mean duration of BS in SE and differences between those suppressed for less than 48 h vs ...
Neville M. Jadeja, Jong Lee
openaire   +2 more sources

Combined use of F22 aligners and intermaxillary elastics in mild skeletal Class II: Two case reports

Journal of orthodontics, 2022
Introduction: The aim of these two case-reports is to illustrate and compare the therapeutic effects of Class II elastics in combination with F22 aligners in an adult and an adolescent patient, respectively.
M. Palone   +3 more
semanticscholar   +1 more source

F22 Novel measures of apathy in huntington’s disease: cross-sectional and longitudinal analysis

F: Clinical studies: case reports, oberservational studies and trials, 2021
Background Apathy is a core symptom of Huntington’s Disease (HD), appearing up to 10 years before the onset of motor symptoms and worsening alongside disease progression. Research into the disease needs greater focus on this symptom, but to date, limited
Emily Hare, D. McLauchlan, A. Rosser
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy